For decades, the idea of a drug that could rewind aspects of human aging has belonged more to science fiction than hospital formularies. That boundary is starting to blur as a gene therapy called ...

Scientists at Life Biosciences are testing a controversial compound, ER-100, aimed at reversing human aging by resetting cells.

As MIT Technology Review reports, Sinclair’s Boston-based startup, Life Biosciences, is working on a treatment code-named ER-100. The company announced on Tuesday that its planned clinical trials had ...

Life Biosciences plans to begin human clinical trials of a cellular rejuvenation therapy in optic neuropathies after ...

Researchers have discovered how pancreatic cancer reprograms its surroundings to spread quickly and stealthily. By using a ...

Dr. Maik Luu discusses how postbiotics can be used to reprogram CAR T cells to promote anti-tumor function and what further ...

The field of cancer research has increasingly focused on the metabolic underpinnings of tumorigenesis, recognizing how the reprogramming of cellular energy ...

From high-tech biohacking to holistic wellness: in the race to live forever, who’s benefitting from the science of longevity?

Type 1 diabetes (T1D) is an autoimmune disorder characterized by the specific destruction of insulin-producing pancreatic ...

The Phase I trial will recruit participants who have been diagnosed with non-arteritic anterior ischaemic optic neuropathy and open-angle glaucoma.

Lipid droplets (LDs) are now recognized as dynamic organelles that regulate diverse cellular processes, including membrane biosynthesis, stress ...

IND clearance marks the first ever cellular rejuvenation therapy using partial epigenetic reprogramming to reach human ...